Pharmafile Logo
Pharmafocus logo
Advanced Search
david_setboun

Industry veteran Dr David Setboun joins BrainStorm as Executive VP and COO

April 3, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing BrainStorm Therapeutics, appointments, pharma

BrainStorm Cell Therapeutics, a firm developing cellular therapies to tackle neurodegenerative diseases, has named industry Big Pharma veteran Dr David …

Appointment
john-mckew-big

Dr John C. McKew promoted to Chief Operating Officer at Lumos Pharma

April 3, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Lumos Pharma, Inc. has promoted Dr John McKew to the position of Chief Operating Officer effective 1 April 2020. McKew …

Appointment
alimera_sciences_logo

Steven T Gill returns to Alimera as VP, Thought Leader Engagement

April 3, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Alimera Sciences, Novartis, pharma

Ophthalmology specialist Alimera Sciences has announced that Steven T Gill is to return to the company in the newly created …

Appointment
top_10_image_2

Top Ten most popular articles on Pharmafile.com this week

April 3, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, coronavirus

COVID-19 coronavirus treatments dominate the news as the world looks for a vaccine. Johnson & Johnson announced that it has …

News
merckwindow_web

MSD’s Keytruda hits Phase 3 main goal in first-line colorectal cancer sub-population

April 3, 2020
Medical Communications, Research and Development MSD, colorectal cancer, keytruda, pharma

MSD has lifted the veil on new Phase 3 for its blockbuster immunotherapy Keytruda, showing that the anti-PD-1 therapy met …

News
cdc_coronavirus

British man charged in the US for smuggling phoney coronavirus cure

April 3, 2020
Medical Communications COVID-19, COVID-19 vaccine, Coronavirus Cure, coronavirus

A British man has been accused of smuggling a fake coronavirus cure into the US and has been federally charged. …

News

Sanofi and Regeneron’s Dupixent combo impresses in paediatric atopic dermatitis

April 3, 2020
Medical Communications, Research and Development Dupixent, Sanofi, atopic dermatitis, pharma

Sanofi and Regeneron have unveiled new Phase 3 data for their IL-4 and IL-13 inhibitor Dupixent (dupilumab), showing strong results …

News
00_chlooorororor

EMA refuses to approve chloroquine for COVID-19 without sufficient data

April 3, 2020
Medical Communications COVID-19, chloroquine, coronavirus

The European Medicines Agency has restricted the general use of the drug chloroquine for coronavirus, but allowing its testing in …

News
0000_hearttt

FDA calls for heartburn drug Zantac to be pulled due to carcinogen concerns

April 2, 2020
Business Services FDA, NDMA, Sanofi, heartburn

The FDA is requesting that manufactures remove Zantac (ranitidine) from the market due to risks of it containing a carcinogen. …

News
blood-75301_1280

US approval for haemophilia drug derived from genetically engineered rabbit’s milk

April 2, 2020
Sales and Marketing FDA, US, haemophilia, pharma

The FDA has announced the approval of Sevenfact, a haemophilia therapy the active ingredient from which is expressed in genetically …

News
00_novartis

FDA places no penalties on Novartis after Zolgensma data manipulation investigation

April 2, 2020
Business Services FDA, Novartis, regulators

The FDA has concluded its investigation into Novartis and its data manipulation of the gene therapy Zolgensma, and has decided …

News
eusa

EUSA Pharma’s COVID-19 drug improves or stabilises respiratory condition in 76% of patients

April 2, 2020
Research and Development COVID-19, Eusa Pharma, coronavirus, ergomed, siltuximab

EUSA Pharma has unveiled promising preliminary findings from an interim analysis of siltuximab in the treatment of serious respiratory complications …

News
tobacco-1831799_960_720

British American Tobacco creating coronavirus vaccine

April 2, 2020
Business Services COVID-19, coronavirus

British American Tobacco has said it is developing a COVID-19 vaccine from tobacco plants. The owner of famous cigarette brands, …

News
000000000000000_tttt

Researchers modify T-cells to identify and target multiple sites on leukaemia cells

April 1, 2020
Research and Development Cancer, Cancers, children cancer, leukaemia

Scientists from the Children’s Hospital of Los Angeles have engineered T-cells to identify and target multiple sites on acute lymphoblastic …

News
pharmafocus_april_2020_cover

The April 2020 issue of Pharmafocus is available to read free online now!

April 1, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, UK, US, coronavirus, generic medicines, pharma, rare disease, real world data, real-world data

The latest monthly edition of Pharmafocus, the April 2020 issue, is available to read for free online now! There’s one …

News
00000000_fda

FDA aims to accelerate COVID-19 therapies with new programme

April 1, 2020
Research and Development COVID-19, FDA, america, coronaviurs

The FDA has launched the Coronavirus Treatment Acceleration Program (CTAP) to quickly bring therapies and treatments to people suffering from …

News
0000000_iran

Europe sells Iran medicine, defying US sanctions

April 1, 2020
Research and Development Iran, Iran Sanctions, Iran US, USA, coronavirus

France, Germany and the UK have announced the sale of medicinal goods to Iran, bypassing US sanctions on the country …

News
lilly_building_with_american_flag_web

Lilly partners with Sitryx in $880m immunometabolism drug development deal

April 1, 2020
Research and Development Eli Lilly, Sitryx, partnership, pharma

Eli Lilly and UK firm Sitryx have partnered up in a new drug development and commercialisation deal that could potentially …

News

Axsome’s late-stage study of experimental depression drug misses main trial goal

March 31, 2020
Manufacturing and Production Depressive Disorder, MDD, depression, migraine

Axsome Therapeutics reported on Monday that its Phase 3 study of its experimental depression drug missed its main trial goal. …

News
000_jjjj

Johnson & Johnson selects lead COVID-19 vaccine candidate and targets September Phase I study

March 31, 2020
Manufacturing and Production . Johnson & Johnson, Johnson & Johnson, Vaccine, coronavirus, coronavirus vaccine

Johnson & Johnson announced that it has selected a candidate for a COVID-19 vaccine from potential constructs it has been …

News
The Gateway to Local Adoption Series

Latest content

Complement Therapeutics’ geographic atrophy treatment receives FDA Fast Track designation

January 22, 2026

PSI appoints David Allen as Country Manager for Canada

January 22, 2026

Qureight appoints Steven Bishop as Chief Medical Officer

January 21, 2026

Pierre Fabre Laboratories and Iktos announce oncology collaboration

January 21, 2026

Qureight appoints Rebecca Simmons as Chief Operating Officer

January 20, 2026